Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

bmiMD vs Evernow

Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, Evernow a 68. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

bmiMD

#11 · Grade A · Great Deal

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full bmiMD review →
VS

Evernow

#276 · Grade C · Watch List

Est. first month

From $49/mo (medication billed separately, brand-name)

Get this deal Full Evernow review →

The verdict

Better value: bmiMD

bmiMD takes it on Value Score, 89 to 68 an est. $99/mo first month, with no teaser step-up baked in. Evernow isn't out of it: Shoppers who want women wanting insurance-covered branded GLP-1 weight loss alongside menopause and HRT care.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealbmiMDEvernow
Value Score89 (A)68 (C)
Est. first month$99/moFrom $49/mo (medication billed separately, brand-name)
Save vs brand-name~93%
Semaglutide$99/moNot disclosed
Tirzepatide$139/moNot disclosed
Both moleculesYesNo
PricingFlat — no step-upWatch
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
90
bmiMD: 95. Evernow: 90.
84
No Teaser-Rate Bait
60
bmiMD: 84. Evernow: 60.
98
Nationwide Availability
45
bmiMD: 98. Evernow: 45.
94
Both Molecules
45
bmiMD: 94. Evernow: 45.
82
Easy Cancellation
58
bmiMD: 82. Evernow: 58.
70
Reputation
75
bmiMD: 70. Evernow: 75.

bmiMD

Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.

Why it's a deal

  • $99 flat semaglutide and a low $139 tirzepatide
  • Available in all 50 states
  • Both molecules priced up front

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Thin public track record; no oral or brand-name option

Evernow

Evernow is a women's-focused, menopause-centered telehealth platform that prescribes branded GLP-1 weight loss medications including Ozempic, Wegovy, Zepbound, and Mounjaro via US-licensed clinicians.

Why it's a deal

  • Prescribes FDA-approved branded GLP-1s, not compounded
  • Accepts insurance for video visits (BCBS, Anthem, UnitedHealthcare, Aetna)
  • Integrates GLP-1 weight loss with menopause and HRT care
  • Flexible one-time visit or low-cost membership models

The fine print

  • Weight loss is one vertical alongside menopause and HRT care
  • GLP-1 medication cost depends on insurance and is not posted
  • State availability not specified on the site
Get the bmiMD deal Get the Evernow deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to Evernow.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.